Copenhagen, Denmark

Lilith Louise Lysgaard Hasbeck

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Coloplast A/s. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lilith Louise Lysgaard Hasbeck. Retrieved from https://idiyas.com/inventor/lilith-louise-lysgaard-hasbeck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lilith Louise Lysgaard Hasbeck: Innovator in Medical Technology

Introduction

Lilith Louise Lysgaard Hasbeck is a notable inventor based in Copenhagen, Denmark. She is currently associated with Coloplast A/S, a company renowned for its innovative medical products. Despite having no patents to her name, her contributions to the field of medical technology are significant.

Latest Patents

As of now, Lilith has not registered any patents. However, her work at Coloplast A/S reflects her commitment to advancing healthcare solutions.

Career Highlights

Lilith has made substantial contributions to her field through her role at Coloplast A/S. Her expertise and dedication have positioned her as a valuable member of the team, focusing on improving patient care and product development.

Collaborations

Lilith collaborates with talented colleagues such as Jonas Emborg and Jesper Kenneth Olsen. Together, they work towards innovative solutions in the medical technology sector.

Conclusion

Lilith Louise Lysgaard Hasbeck is an inspiring figure in the realm of medical innovation. Her work at Coloplast A/S showcases her dedication to enhancing healthcare, even in the absence of patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…